"Penicillamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
| Descriptor ID |
D010396
|
| MeSH Number(s) |
D02.886.030.786 D12.125.166.786
|
| Concept/Terms |
Penicillamine- Penicillamine
- Mercaptovaline
- D-Penicillamine
- D Penicillamine
- Dimethylcysteine
- beta,beta-Dimethylcysteine
- beta,beta Dimethylcysteine
- D-3-Mercaptovaline
- D 3 Mercaptovaline
|
Below are MeSH descriptors whose meaning is more general than "Penicillamine".
Below are MeSH descriptors whose meaning is more specific than "Penicillamine".
This graph shows the total number of publications written about "Penicillamine" by people in this website by year, and whether "Penicillamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Penicillamine" by people in Profiles.
-
Nikeghbalian S, Atefi S, Kazemi K, Roshan N, Tanideh N, Jalaeian H. Effect of oral D-penicillamine vs. colchicine on experimentally induced peritoneal adhesions in rats. Fertil Steril. 2007 Oct; 88(4 Suppl):1187-9.
-
Mannick JB, Stamler JS, Teng E, Simpson N, Lawrence J, Jordan J, Finberg RW. Nitric oxide modulates HIV-1 replication. J Acquir Immune Defic Syndr. 1999 Sep 01; 22(1):1-9.
-
Engelbrecht V, Schlaug G, Hefter H, Kahn T, M?dder U. MRI of the brain in Wilson disease: T2 signal loss under therapy. J Comput Assist Tomogr. 1995 Jul-Aug; 19(4):635-8.
-
Schlaug G, Hefter H, Nebeling B, Engelbrecht V, Weiss P, St?cklin G, Seitz RJ. Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease. J Neurol. 1994 Oct; 241(10):577-84.